Delivery Order SPE2DB20D9354-SPE2DB25FX7K2

Award Date 1/8/25
Potential Completion Date 1/9/25
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,526.83 firm fixed-price contract is for the supply of TRIKAFTA 100-50-75 MG/75MG PKT 14S, a specialized pharmaceutical product. The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure this direct...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $74,107.32, is for the supply of TRIKAFTA 100-50-75 MG/75MG PKT 14S, a specialized pharmaceutical product, to support the medical supply needs of military health facilities. The delivery order is part of a larger Indefinite Delivery Contract (IDC) held by DMS...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,526.83 award is for the delivery of the pharmaceutical product TRIKAFTA 100-50-75 MG/150 MG UU 84S. This is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA to provide a comprehensive range of...
This federal contract award, valued at $74,107.32, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of TRIKAFTA 100-50-75 MG/150 MG, a specialized pharmaceutical product, to support the recurring medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. holds a larger Indefinite...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,526.83 contract is for the supply of the drug TRIKAFTA 50-25-37.5 MG/75 MG to the Defense Logistics Agency (DLA), the agency responsible for providing logistics, acquisition, and technical services to the U.S. military. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,526.83 firm fixed-price delivery order is for the supply of TRIKAFTA 100-50-75 MG/150 MG pharmaceutical products. The award is part of a larger indefinite delivery contract (IDC) with a ceiling value of up to $499,999,999, which allows the DLA to issue delivery orders for a comprehensive...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $54,956.25 contract is for the delivery of Trikafta, a specialized prescription medication, to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,488.12 contract is for the provision of the prescription drug TRIKAFTA 100-50-75 MG/150 MG, with a period of performance through January 22, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $37,053.68 contract is to provide the pharmaceutical product TRIKAFTA 100-50-75 MG/75MG PKT 14S to support the recurring medical supply needs of military health facilities. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract award, valued at $37,053.68, is for the delivery of Trikafta 100-50-75 mg/150 mg medication to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery...
  • SPE2DB20D9354
    Indefinite Delivery Contract
  • SPE2DB20D9354-SPE2DB25FX7K2
    Delivery Order

This is a firm fixed-price delivery order contract valued at $18,488.12, awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the provision of TRIKAFTA 100-50-75 MG/150 MG UU 84S, a pharmaceutical product, to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide.

DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items. This contract award is issued under that IDC and does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains. The contract has an ultimate completion date of January 9, 2025.

Generated 4/9/25, 9:55 AM